Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

IBD

This page shows the latest IBD news and features for those working in and with pharma, biotech and healthcare.

Communiqué: big wins for obesity and sugar tax campaigners

Communiqué: big wins for obesity and sugar tax campaigners

Specialist healthcare communications group Sciterion (pictured below) won the Excellence in Communications via a Live Event or Stand-Alone Activity accolade for its Live Multi-site National IBD Meeting. ... Meanwhile, Aurora Healthcare Communications’

Latest news

More from news
Approximately 12 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    The deal also includes a licence to AKB-5169 (formerly JNJ5169), an oral, preclinical stage compound for inflammatory bowel disease (IBD). ... Joint venture. 286.3. Janssen/ Akebia Therapeutics. HIF-targeting candidates inc AKB-5169 for IBD (pc) plus

  • Deal Watch June 2016 Deal Watch June 2016

    IBD). PF-00547659 targets a gastrointestinal endothelial adhesion molecule known as mucosal addressin cell adhesion molecule 1 (MAdCAM-1) that binds to the α4β7 integrin on lymphocytes.

  • Deal Watch October 2015 Deal Watch October 2015

    Janssen's partnership with Canadian biotech enGene, facilitated through J&J Innovation, brings gene therapies for inflammatory bowel disease (IBD) and includes an undisclosed upfront payment and equity investment, R&D ... Research collaboration, option,

  • Pharma deals in June 2015 Pharma deals in June 2015

    the treatment of inflammatory bowel disease (IBD). ... 130. Lycera Corporation/ Celgene Corporation. Orally bioavailable RORgamma agonists for ex vivo use lead programme, LYC-30937 (oral gut-directed ATPase modulator for IBD, p1).

  • Getting real about patient support Getting real about patient support

    opposed to a series of acute episodes (such as in asthma, COPD or IBD).

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Pharma and NHS working together for patients - the IBD Registry Industry Working Group

    Pharma and NHS working together for patients - the IBD Registry Industry Working Group. ... Recently, we spoke to members of the IBD Registry Industry Working Group about what they’ ve achieved in their first year, and whether or not it’ s been

  • Joined-up thinking on anaemia

    Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’ s quality of life, but it’ s often under-treated. ... The partners share resources and skills and the project is the first to use the IBD

  • IBD Registry appoints first CEO

    2018. The IBD Registry is familiar to many as the first UK-wide collection of anonymised adult and paediatric IBD data for prospective audit and research. ... Amanda Quincey, current Chair of the IBD Registry Board commented, “ the Board are delighted

  • Therapy Watch expands oncology and IBD portfolios

    Therapy Watch expands oncology and IBD portfolios. This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new

  • Biosimilars: Getting the flock to market

    could halve the cost of IBD treatment.

More from PMHub
Approximately 5 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Quick links

Infographics

Multimedia